This policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.
This policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.
Kura Oncology already had a broad development plan for ziftomenib in leukemias,...
ByglobalreutersNovember 21, 2024Enhanced Affordable Care Act (ACA) subsidies lower premium payments for ACA Marketplace...
ByglobalreutersNovember 21, 2024Hip replacement surgery is one of the most common and successful medical...
ByglobalreutersNovember 21, 2024From Tyler Cowen at Marginal Revolution: One of the problems with an...
ByglobalreutersNovember 21, 2024
Leave a comment